Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial-Reference-Cited by-同舟云学术

Testing the efficacy of INtegral Cognitive REMediation (INCREM) in major depressive disorder: study protocol for a randomized clinical trial

Published:2019-05-06 Issue:1 Volume:19 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Vicent-Gil Muriel,Raventós Beatriz,Marín-Martínez Eduardo D.,González-Simarro Sara,Martínez-Arán Anabel,Bonnin Caterina del Mar,Trujols Joan,Pérez-Blanco Josefina,de Diego-Adeliño Javier,Puigdemont Dolors,Serra-Blasco Maria,Cardoner Narcís,Portella Maria J.^ORCID

Funder

Spanish Ministry of Science and Innovation, Instituto Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/s12888-019-2117-4.pdf

Reference49 articles.

1. McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30:515–27.

2. Chakrabarty T, Hadjipavlou G, Lam RW. Cognitive dysfunction in major depressive disorder: assessment, impact, and management. J Lifelong Learn Psychiatry. 2016;14:194–206.

3. Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145:39–48.